You can buy or sell DaVita and other stocks, options, ETFs, and crypto commission-free!
DaVita, Inc. engages in the provision of medical care services. It operates through the following two segments: US Dialysis and Related Lab Services; and Other-Ancillary Services and Strategic Initiatives. Read More The US Dialysis and Related Lab Services segment offers kidney dialysis services in the United States for patients suffering from chronic kidney failure. The Other-Ancillary Services and Strategic Initiatives segment consist primarily of pharmacy services, disease management services, vascular access services, clinical research programs, physician services, direct primary care, end stage renal disease seamless care organizations, and comprehensive care. The company was founded in 1994 and is headquartered in Denver, CO.
52 Week High
52 Week Low
Latest Change: DaVita (NYSE: DVA)
DaVita trades as part of the health care providers industry and is in the healthcare sector. The company CEO is Kent J. Thiry. DaVita Inc is engaged in operating kidney dialysis centers and providing related lab services in dialysis centers and in contracted hospitals across USA. It also operates other ancillary services and strategic initiatives. Previous Intraday Trading Performance: The DVA stock showed a previous change of -0.09% with an open at 53.60 and a close of 53.53. It reached an intraday high ...
Yahoo FinanceMar 15
DaVita HealthCare (DVA) Down 7.8% Since Last Earnings Report: Can It Rebound?
A month has gone by since the last earnings report for DaVita HealthCare (DVA). Shares have lost about 7.8% in that time frame, underperforming the S&P 500. Will the recent negative trend continue leading up to its next earnings release, or is DaVita HealthCare due for a breakout? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. DaVita Q4 Earnings Beat on Increasing D...
Expected May 2, After Hours